Our Purpose is to redefine injectable
drug delivery by eliminating instability, waste,
and cold-chain dependence.

Professor Boris Zubry, MBA, MSME – Founder, Chairman and Inventor of the Proposed Injection System.

Boris is the inventor and developer of the patented magnetic plungerless injection system (MIST) technology that will be the first product launched by Avicenna Therapeutic Tech, Inc., a DE C-corp . As an engineering and education professional, he has extensive experience in Management, Capital Project Management, Engineering, Operations, Maintenance, and Training in the Pharmaceutical, Cosmetics, Processing and Packaging Machinery, and the Food Industries.

He was the Project Director for multiple projects in Eastern Europe and the Middle East (Boris is fluent in a couple of languages) for Italcom, managing budgets, vendors, and suppliers, and supervising projects and personnel in Poland's sales offices, Russia, and Ukraine. Boris has considerable work experience with large Pharmaceutical firms such as Bristol Myers Squibb, Johnson & Johnson, and Alza Corp, serving as a plant engineer, engineer, and project manager.

In addition, Boris has extensive knowledge and experience in packaging, serving as a capital project manager and packaging engineering manager at Barnes-Hind, SPIMACO (Saudi Arabia), L'Oreal USA, GAF Materials, and West Pharmaceutical Services. He is experienced in project initiation and development, budget control and management, and vendor/supplier management. Boris has extensive patent experience and has been involved in multiple patent filings over his long business career.

Over the last 10 years, he has been an Assistant Professor of Math, Physics, GMP/cGMP, Green manufacturing, Quality Control, Nanotechnology, and Information Technology at Community College of Philadelphia, Rutgers University, Mercer County College, and Rider University, amongst others.

Dr. Tirotta is the Chief Executive officer of Avicenna Therapeutic Tech, Inc., a DE C-corp. , having been appointed to this position in January 2026. Dr. Tirotta is also currently employed by Christopher F. Tirotta, MD, MBA, Inc. providing locum tenens coverage to pediatric hospitals. Previously Dr. Tirotta was an active member of Miami Children's Hospital medical staff from 1991 to 2023, practicing with the Department of Anesthesiology; he served as the Director of Cardiac Anesthesia from November 2002 to July 2017. He has served as Chief of the Department of Anesthesia from July 2017 to February 2023. He also had a clinical appointment with the Department of Anesthesiology at The University of Miami School of Medicine. He has been involved with a member of medical device and pharmaceutical start-ups in his career.

Dr. Tirotta received his BA from Cornell University in 1982 and his MD from New York University School of Medicine in 1986. He also received an MBA degree from Columbia University in 1999. Dr. Tirotta completed his internship in Internal Medicine at SUNY at Stony Brook in 1987. He completed his residency training in anesthesiology at the University of Miami/Jackson Memorial Hospital in 1990; he sub-specialized in pediatric and cardiovascular anesthesia, including heart transplantation.

In 1994, Dr. Tirotta created and produced the widely acclaimed pre-operative educational video titled, "A Hospital Trip with Dr. Bip". This program, narrated by the endearing animated character Dr. Bip, explains to young children what to expect when they go to the hospital for surgery. It also includes coloring books and stickers. This program was exhibited at numerous national medical conventions and has sold thousands of copies all over the English-speaking world.

Dr. Tirotta is a member of numerous professional societies and has served on a number of hospital committees, including the Heart Program Executive Committee, the OR Governance Council and the Medical Executive Committee; he also chairs the Sedation Council. He previously served as the Co-Chair of the Miami Children's Hospital Physician Hospital Organization. He is also responsible for giving numerous medical lectures nationally and internationally and is actively engaged in clinical research, publishing multiple manuscripts in peer-reviewed journals. He has been the Principal Investigator on a number of clinical drug/device trials, including on the ONQ Pain Buster, the muscle relaxant Zemuron, the procoagulant RiaSTAP, the Cardiotronic NICOM device, the ClearLine, and the long-acting local anesthetic Exparel. He is also the Principal Investigator for Merck's Sugammadex pediatric trial, Pacira Pharmaceuticals pediatric Exparel trial and Pfizer's dexmedetomidine pediatric sedation trial.

Dr. Tirotta was inducted into Phi Beta Kappa in 1982, was inducted into Beta Gamma Sigma in 1999, graduated Cum Laude from Cornell University and was the recipient of the Robert D. Dripps Memorial Award for the outstanding graduate resident in anesthesiology in 1990. He is a Diplomat of the American Board of Anesthesiology, is sub-specialty certified in Pediatric Anesthesia and a Diplomat of the National Board of Medical Examiners. He is also a Fellow of the American Society of Anesthesiology. He is licensed to practice medicine in the states of Florida, New York, Arkansas, Pennsylvania, Kentucky, South Carolina, Mississippi, Vermont and Idaho.

Christopher Meatto is the Managing Partner of HL74, a founder-focused advisory and legal platform whose roots trace back to his Harvard Law School background and entrepreneurial experience building and advising emerging companies. For more than twenty years, he has advised startup and growth-stage businesses on corporate strategy, seed and Series A financings, governance, and business development.

After graduating with honors from Harvard Law School, he spent seven years as a litigation associate at major New York City law firms before founding Meatto Russo Burke & Wallace. The firm went on to represent Swatch Watch and the Swiss watch industry in its international anti-counterfeiting initiatives, while also serving as corporate counsel during the launch of the Swatch brand in the United States.

Long before startups became institutionalized and venture capital became mainstream, he stepped away from traditional legal practice to launch and operate his own fashion watch company. That entrepreneurial experience continues to shape the way he advises founders today — with a practical understanding of the challenges involved in building, financing, scaling, and protecting a business.

He later returned to focus on New York’s early technology startup ecosystem and founded NYCG.COM to provide integrated legal and strategic support to emerging companies and entrepreneurs.

Today, through harvardlaw74 and HL74, he continues to work closely with founders, startups, and growth-stage businesses navigating capital raises, corporate structuring, strategic partnerships, and long-term growth.

Outside of work, he is a lifelong Manchester United supporter, an active member of the Harvard Club of New York City, and lives in Hoboken with his wife and their Corgi, Harvey.